Emerging Credit Rating Limited (ECRL) has affirmed AA+ (Pronounced as Double A Plus) long term credit rating and ST-1 short term credit rating to Eskayef Pharmaceuticals Limited. The outlook of the rating is Stable. The rating is based on the audited financial statements for FY2019-2022 and other relevant qualitative and quantitative information up to the date of rating.